Daily BriefsPrivate Markets

Daily Brief Private Markets: Halodoc Raises $100m Series D in Astra-Led Round and more

In today’s briefing:

  • Halodoc Raises $100m Series D in Astra-Led Round
  • Ex-Gojek VP’s Modern Financial Analytics Platform Bunker Secures US$5M
  • Immuno Cure Bags US$12M Series A Funding, Gears up for Hong Kong IPO
  • Vietnam Edtech Firm Vuihoc Bags $6m in TNB Aura-Led Round


Halodoc Raises $100m Series D in Astra-Led Round

By Tech in Asia

  • Halodoc, the Indonesia-based healthtech firm, raked in US$100 million in series D funding in a round led by returning investor Astra Digital International, according to a statement.
  • This boosts Astra’s total investments in the company to US$135 million. In 2021, the local conglomerate also led the US$80 million series C round of Halodoc.
  • With the new capital, Halodoc has raised at least US$258 million, according to Tech in Asia data.

Ex-Gojek VP’s Modern Financial Analytics Platform Bunker Secures US$5M

By e27

  • Singapore-based startup Bunker, which provides a modern financial analytics platform for SMEs, has secured over US$5 million over two funding rounds.
  • The investors include January Capital, Alpha JWC, GFC, Northstar Group, Money Forward, Alpine Ventures, and Patamar Capital.
  • Angel investors, namely Chris Lin, Rosemary DeAaragon, Tiger Fang, Gaurav Gupta, Christian Sutardi, Warren Tseng, Jonathan Wong, Nakul Malhotra, and Shaun Hon, also participated.

Immuno Cure Bags US$12M Series A Funding, Gears up for Hong Kong IPO

By e27

  • Hong Kong-based Immuno Cure BioTech has closed the US$12 million tranche of its US$27 million Series A fundraising round, led by Gobi Partners-managed AEF Greater Bay Area Fund.
  • The biotech company will use the capital to accelerate the development of DNA vaccines and antibodies besides preparing for an IPO in Hong Kong.
  • Immuno Cure focuses on R&D of immunotherapies for cancers, inflammatory and infectious diseases based on its patented “PD-1-enhanced DNA Vaccine Platform” and “Anti-Δ42PD1 Antibody Platform” with two DNA vaccine candidates, ICVAX and ICCOV, currently in clinical trials.

Vietnam Edtech Firm Vuihoc Bags $6m in TNB Aura-Led Round

By Tech in Asia

  • Vietnam’s e-learning market is expected to hit US$3 billion in value by the end of the year. Increased internet accessibility, coupled with ICT advancements and the rise in smartphone users, is driving the growth of online learning in the country.
  • In a bid to capitalize on this demand, local edtech firm Vuihoc has raised US$6 million in its series A funding round led by TNB Aura.
  • The fresh funds will be used to improve the company’s product offerings and invest in AI to offer personalized learning experiences for students.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars